|
US5506337A
(en)
|
1985-03-15 |
1996-04-09 |
Antivirals Inc. |
Morpholino-subunit combinatorial library and method
|
|
US4797368A
(en)
|
1985-03-15 |
1989-01-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adeno-associated virus as eukaryotic expression vector
|
|
US5139941A
(en)
|
1985-10-31 |
1992-08-18 |
University Of Florida Research Foundation, Inc. |
AAV transduction vectors
|
|
US5010175A
(en)
|
1988-05-02 |
1991-04-23 |
The Regents Of The University Of California |
General method for producing and selecting peptides with specific properties
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
IE66205B1
(en)
|
1990-06-14 |
1995-12-13 |
Paul A Bartlett |
Polypeptide analogs
|
|
US5650489A
(en)
|
1990-07-02 |
1997-07-22 |
The Arizona Board Of Regents |
Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
|
|
US5384253A
(en)
|
1990-12-28 |
1995-01-24 |
Dekalb Genetics Corporation |
Genetic transformation of maize cells by electroporation of cells pretreated with pectin degrading enzymes
|
|
WO1993004169A1
(en)
|
1991-08-20 |
1993-03-04 |
Genpharm International, Inc. |
Gene targeting in animal cells using isogenic dna constructs
|
|
CA2117096C
(en)
|
1991-09-06 |
1997-11-04 |
Masafumi Arita |
4-amino(alkyl)cyclohexane-1-carboxamide compound and use thereof
|
|
US5573905A
(en)
|
1992-03-30 |
1996-11-12 |
The Scripps Research Institute |
Encoded combinatorial chemical libraries
|
|
US5702932A
(en)
|
1992-07-20 |
1997-12-30 |
University Of Florida |
Microinjection methods to transform arthropods with exogenous DNA
|
|
US5288514A
(en)
|
1992-09-14 |
1994-02-22 |
The Regents Of The University Of California |
Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support
|
|
CA2167580A1
(en)
|
1993-07-22 |
1995-02-02 |
Howard Y. Chen |
Expression of human interleukin-1.beta. in a transgenic animal
|
|
US5519134A
(en)
|
1994-01-11 |
1996-05-21 |
Isis Pharmaceuticals, Inc. |
Pyrrolidine-containing monomers and oligomers
|
|
US5593853A
(en)
|
1994-02-09 |
1997-01-14 |
Martek Corporation |
Generation and screening of synthetic drug libraries
|
|
US5539083A
(en)
|
1994-02-23 |
1996-07-23 |
Isis Pharmaceuticals, Inc. |
Peptide nucleic acid combinatorial libraries and improved methods of synthesis
|
|
US5656610A
(en)
|
1994-06-21 |
1997-08-12 |
University Of Southern California |
Producing a protein in a mammal by injection of a DNA-sequence into the tongue
|
|
US5525735A
(en)
|
1994-06-22 |
1996-06-11 |
Affymax Technologies Nv |
Methods for synthesizing diverse collections of pyrrolidine compounds
|
|
US5549974A
(en)
|
1994-06-23 |
1996-08-27 |
Affymax Technologies Nv |
Methods for the solid phase synthesis of thiazolidinones, metathiazanones, and derivatives thereof
|
|
US5736524A
(en)
|
1994-11-14 |
1998-04-07 |
Merck & Co.,. Inc. |
Polynucleotide tuberculosis vaccine
|
|
US5843780A
(en)
|
1995-01-20 |
1998-12-01 |
Wisconsin Alumni Research Foundation |
Primate embryonic stem cells
|
|
WO1997000271A1
(en)
|
1995-06-14 |
1997-01-03 |
The Regents Of The University Of California |
Novel high affinity human antibodies to tumor antigens
|
|
US5569588A
(en)
|
1995-08-09 |
1996-10-29 |
The Regents Of The University Of California |
Methods for drug screening
|
|
US6013516A
(en)
|
1995-10-06 |
2000-01-11 |
The Salk Institute For Biological Studies |
Vector and method of use for nucleic acid delivery to non-dividing cells
|
|
US5780448A
(en)
|
1995-11-07 |
1998-07-14 |
Ottawa Civic Hospital Loeb Research |
DNA-based vaccination of fish
|
|
GB9807935D0
(en)
|
1998-04-14 |
1998-06-10 |
Univ Edinburgh |
Lineage specific cells and progenitor cells
|
|
US5945100A
(en)
|
1996-07-31 |
1999-08-31 |
Fbp Corporation |
Tumor delivery vehicles
|
|
JP3669711B2
(ja)
|
1996-08-12 |
2005-07-13 |
三菱ウェルファーマ株式会社 |
Ｒｈｏキナーゼ阻害剤を含有する医薬
|
|
US5981274A
(en)
|
1996-09-18 |
1999-11-09 |
Tyrrell; D. Lorne J. |
Recombinant hepatitis virus vectors
|
|
EP0981352B8
(en)
|
1997-05-07 |
2009-06-17 |
Pharma Mar, S.A. |
Use of aplidine for the treatment of cardiovascular diseases
|
|
US6270994B1
(en)
|
1997-06-13 |
2001-08-07 |
Japanese Foundation For Cancer Research |
Smad6 and uses thereof
|
|
CN1163475C
(zh)
|
1997-07-01 |
2004-08-25 |
沃尼尔·朗伯公司 |
4-溴或4-碘苯基氨基苯氧肟酸衍生物及其作为mek抑制剂的用途
|
|
US5994624A
(en)
|
1997-10-20 |
1999-11-30 |
Cotton Incorporated |
In planta method for the production of transgenic plants
|
|
US5994136A
(en)
|
1997-12-12 |
1999-11-30 |
Cell Genesys, Inc. |
Method and means for producing high titer, safe, recombinant lentivirus vectors
|
|
US20060263382A1
(en)
|
1998-06-20 |
2006-11-23 |
Richard Hotchkiss |
Membrane-permeant peptide complexes for treatment of sepsis
|
|
JP2002521025A
(ja)
|
1998-07-24 |
2002-07-16 |
ザ カーネギー インスチチューション オブ ワシントン |
増殖因子のＴＧＦ−βファミリーのメンバーを使用する、生殖系列幹細胞の維持および増殖のための方法。
|
|
GB9819912D0
(en)
|
1998-09-11 |
1998-11-04 |
Univ Edinburgh |
Propagation and/or derivation of embryonic stem cells
|
|
CA2350234A1
(en)
|
1999-01-07 |
2000-07-13 |
Alexander James Bridges |
Treatment of asthma with mek inhibitors
|
|
US6703420B1
(en)
|
1999-03-19 |
2004-03-09 |
Bristol-Myers Squibb Pharma Company |
Amino-thio-acrylonitriles as MEK inhibitors
|
|
WO2000078351A1
(en)
|
1999-06-18 |
2000-12-28 |
Mitsubishi Pharma Corporation |
Osteogenesis promoters
|
|
US6730293B1
(en)
|
1999-08-24 |
2004-05-04 |
Cellgate, Inc. |
Compositions and methods for treating inflammatory diseases of the skin
|
|
AU6865100A
(en)
|
1999-09-02 |
2001-04-10 |
Mitsubishi Pharma Corporation |
Osteogenesis promoting agents
|
|
US20020142457A1
(en)
|
1999-12-28 |
2002-10-03 |
Akihiro Umezawa |
Cell having the potentiality of differentiation into cardiomyocytes
|
|
US6692736B2
(en)
|
2000-03-24 |
2004-02-17 |
Cell Genesys, Inc. |
Cell-specific adenovirus vectors comprising an internal ribosome entry site
|
|
JP3811775B2
(ja)
|
2000-07-19 |
2006-08-23 |
ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー |
４−ヨードフェニルアミノベンズヒドロキサム酸の酸素化エステル
|
|
CA2441492C
(en)
|
2001-03-23 |
2011-08-09 |
Bayer Corporation |
Rho-kinase inhibitors
|
|
AR035792A1
(es)
|
2001-03-23 |
2004-07-14 |
Bayer Corp |
Compuestos de n-(4-quinazolinil)-n-(1h-indazol-5-il) amina, inhibidor de la rho-quinasa, su uso para la fabricacion de un medicamento y metodo para prepararlo
|
|
EP1385946B1
(en)
|
2001-05-01 |
2009-12-23 |
National Research Council Of Canada |
A system for inducible expression in eukaryotic cells
|
|
EP1437403A4
(en)
|
2001-09-21 |
2004-10-27 |
Japan Science & Tech Corp |
METHOD FOR PATTERNING REPROGRAMMING FACTOR, METHOD OF PATTERNED REPROGRAMMING FACTOR, METHOD FOR USE OF REPROGRAMMING FACTOR, METHOD FOR DIFFERENTIATING AND SIFE-INGENATING FAN
|
|
SI1456380T1
(sl)
|
2001-11-02 |
2012-11-30 |
Giuliani Int Ltd |
Smad inhibitorji za zdravljenje cns bolezni
|
|
EP1465900B1
(en)
|
2002-01-10 |
2008-05-14 |
Bayer HealthCare AG |
Rho-kinase inhibitors
|
|
JP4423043B2
(ja)
|
2002-01-23 |
2010-03-03 |
バイエル ファーマセチカル コーポレーション |
Ｒｈｏ−キナーゼ阻害剤
|
|
EP1470121B1
(en)
|
2002-01-23 |
2012-07-11 |
Bayer HealthCare LLC |
Pyrimidine derivatives as rho-kinase inhibitors
|
|
US20030204862A1
(en)
|
2002-03-05 |
2003-10-30 |
Ralf Kuehn |
Inbred embryonic stem-cell derived mice
|
|
ZA200407220B
(en)
|
2002-03-13 |
2007-05-30 |
Array Biopharma Inc |
N3 alkylated benzimidazole derivatives as MEK inhibitors
|
|
WO2003082808A1
(en)
|
2002-04-03 |
2003-10-09 |
Sumitomo Pharmaceuticals Company, Limited. |
Benzamide derivatives
|
|
GB0210539D0
(en)
|
2002-05-08 |
2002-06-19 |
Univ Edinburgh |
Control of es cell self renewal and lineage specification, and medium therefor
|
|
DE50304983D1
(de)
|
2002-10-28 |
2006-10-19 |
Bayer Healthcare Ag |
Heteroaryloxy-substituierte phenylaminopyrimidine als rho-kinaseinhibitoren
|
|
CA2506085A1
(en)
|
2002-11-15 |
2004-06-03 |
Ronald Lynn Merriman |
Combination chemotherapy comprising a mek inhibitor and capecitabine for treating cancer
|
|
KR101156745B1
(ko)
|
2002-12-16 |
2012-06-15 |
테크니온 리서치 앤드 디벨롭먼트 파운데이션 리미티드 |
지지세포 비함유, 이종 비함유의 인간 배아줄기세포의 조제방법 및 이들을 사용하여 조제되는 줄기세포 배양물
|
|
JP2006517234A
(ja)
|
2003-02-10 |
2006-07-20 |
アムジエン・インコーポレーテツド |
バニロイド受容体リガンドおよび治療におけるこれらのリガンドの使用
|
|
AU2003901099A0
(en)
|
2003-03-11 |
2003-03-27 |
Es Cell International Pte Ltd. |
Methods of inducing differentiation of stem cells
|
|
US20050075276A1
(en)
|
2003-03-14 |
2005-04-07 |
Christopher Rudd |
Use of inhibitors of glycogen synthase-3 to augment CD28 dependent -T-cell responses
|
|
US20070010008A1
(en)
|
2005-06-29 |
2007-01-11 |
Tissuetech, Inc. |
Ex vivo expansion of primary animal cells
|
|
CA2529752A1
(en)
|
2003-06-20 |
2005-09-15 |
The Regents Of The University Of California |
Polypeptide transduction and fusogenic peptides
|
|
CN1863904B
(zh)
|
2003-10-03 |
2014-05-28 |
福田惠一 |
由干细胞分化诱导心肌细胞的方法
|
|
EP2468729B1
(en)
|
2003-10-15 |
2013-12-25 |
Ube Industries, Ltd. |
Novel indazole derivative
|
|
JP2007508026A
(ja)
|
2003-10-16 |
2007-04-05 |
ザ・ユニバーシティ・コート・オブ・ザ・ユニバーシティ・オブ・エディンバラ |
Ｅｓ細胞の自己再生および系統仕様の制御ならびにそのための培地
|
|
US20070141703A1
(en)
|
2003-11-19 |
2007-06-21 |
Stanley Edouard G |
Methods for producing blood products from pluripotent cells in cell culture
|
|
EP1689233B1
(en)
|
2003-11-19 |
2012-07-04 |
Array Biopharma, Inc. |
Bicyclic inhibitors of mek
|
|
US20070269412A1
(en)
|
2003-12-02 |
2007-11-22 |
Celavie Biosciences, Llc |
Pluripotent cells
|
|
EP1713775A4
(en)
|
2004-01-30 |
2009-08-12 |
Smithkline Beecham Corp |
CHEMICAL COMPOUNDS
|
|
WO2005108416A2
(en)
|
2004-04-21 |
2005-11-17 |
The University Of Chicago |
Myosin light chain kinase inhibitors and their use
|
|
JP5102030B2
(ja)
|
2004-08-13 |
2012-12-19 |
ユニバーシティ・オブ・ジョージア・リサーチ・ファウンデイション・インコーポレイテッド |
ヒト胚性幹細胞における自己再生および分化のための組成物および方法
|
|
US20080268533A1
(en)
|
2004-08-25 |
2008-10-30 |
University Of Georgia Research Foundation, Inc. |
Methods and Compositions Utilizing Myc and Gsk3Beta to Manipulate the Pluripotency of Embryonic Stem Cells
|
|
US20060182724A1
(en)
|
2005-02-15 |
2006-08-17 |
Riordan Neil H |
Method for expansion of stem cells
|
|
SG177981A1
(en)
|
2005-05-18 |
2012-02-28 |
Array Biopharma Inc |
4-(phenylamino)-6-oxo-1, 6-dihydropyridazine-3-carboxamide derivatives as mek inhibitors for the treatment of hyperproliferative diseases
|
|
KR101004634B1
(ko)
|
2005-08-01 |
2011-01-04 |
뉴포텐셜, 인크. |
잠재력이 복원된 리프로그래밍된 세포의 제조
|
|
US20080242594A1
(en)
|
2005-09-08 |
2008-10-02 |
Mckay Ronald D G |
Methods for Promoting Stem Cell Proliferation and Survival
|
|
US8217042B2
(en)
|
2005-11-11 |
2012-07-10 |
Zentaris Gmbh |
Pyridopyrazines and their use as modulators of kinases
|
|
US20090227032A1
(en)
|
2005-12-13 |
2009-09-10 |
Kyoto University |
Nuclear reprogramming factor and induced pluripotent stem cells
|
|
WO2007069666A1
(ja)
|
2005-12-13 |
2007-06-21 |
Kyoto University |
核初期化因子
|
|
GB0601538D0
(en)
|
2006-01-26 |
2006-03-08 |
Univ Birmingham |
Epigenetic analysis
|
|
EP1992360A4
(en)
|
2006-02-01 |
2010-02-17 |
Univ Tokyo |
COMMON USE OF A TGF BETA SIGNAL HEMMER AND AN ANTITUMORAL AGENT
|
|
US7541186B2
(en)
|
2006-02-22 |
2009-06-02 |
University Of Washington |
Method of generating human retinal progenitors from embryonic stem cells
|
|
GB0615327D0
(en)
|
2006-03-30 |
2006-09-13 |
Univ Edinburgh |
Culture medium containing kinase inhibitors and uses thereof
|
|
EP2457995A1
(en)
|
2006-03-30 |
2012-05-30 |
The University Court of The University of Edinburgh |
Culture medium containing kinase inhibitors, and uses thereof
|
|
US8741643B2
(en)
|
2006-04-28 |
2014-06-03 |
Lifescan, Inc. |
Differentiation of pluripotent stem cells to definitive endoderm lineage
|
|
GB2452186B
(en)
|
2006-05-02 |
2011-01-26 |
Wisconsin Alumni Res Found |
Method of differentiating stem cells into cells of the endoderm and pancreatic lineage
|
|
US20070298496A1
(en)
|
2006-06-23 |
2007-12-27 |
Hung-Chih Kuo |
Method of deriving pluripotent stem cells from a single blastomere
|
|
US7884107B2
(en)
|
2006-06-30 |
2011-02-08 |
Merck |
Substituted piperidines that increase P53 activity and the uses thereof
|
|
JP4960450B2
(ja)
|
2006-07-14 |
2012-06-27 |
ノバルティス アーゲー |
Ａｌｋ−５阻害剤としてのピリミジン誘導体
|
|
US20080020014A1
(en)
|
2006-07-19 |
2008-01-24 |
Paul Consigny |
Implantable devices containing nuclear receptor ligands for the treatment of vascular and related disorders
|
|
ZA200901914B
(en)
|
2006-09-22 |
2010-06-30 |
Riken |
Stem cell culture medium and method
|
|
JP2008099662A
(ja)
|
2006-09-22 |
2008-05-01 |
Institute Of Physical & Chemical Research |
幹細胞の培養方法
|
|
GB0622395D0
(en)
|
2006-11-09 |
2006-12-20 |
Univ Cambridge Tech |
Methods relating to pluripotent cells
|
|
WO2008089351A1
(en)
|
2007-01-17 |
2008-07-24 |
Wisconsin Alumni Research Foundation |
Improved culture of stem cells
|
|
US20100172883A1
(en)
|
2007-01-19 |
2010-07-08 |
Bruneau Benoit Gaetan |
Methods of generating cardiomyocytes
|
|
CA2676044C
(en)
|
2007-01-30 |
2019-10-22 |
University Of Georgia Research Foundation, Inc. |
Early mesoderm cells, a stable population of mesendoderm cells that has utility for generation of endoderm and mesoderm lineages and multipotent migratory cells (mmc)
|
|
WO2008105630A1
(en)
|
2007-02-27 |
2008-09-04 |
Procell Therapeutics Inc. |
Combined use of cell permeable nanog and oct4 for increasing self-renewal and suppressing differentiation of stem cells
|
|
EP3449923A1
(en)
|
2007-03-07 |
2019-03-06 |
MEI Pharma, Inc. |
Combination of benzimidazole anti-cancer agent and a second anti-cancer agent
|
|
WO2008126932A2
(en)
|
2007-04-09 |
2008-10-23 |
Riken |
Epigenetical regulation of brain plasticity
|
|
EP2147094B2
(en)
|
2007-04-18 |
2018-02-21 |
Hadasit Medical Research Services & Development Limited |
Stem cell-derived retinal pigment epithelial cells
|
|
US7878210B2
(en)
|
2007-06-04 |
2011-02-01 |
Philip Morris Usa Inc. |
Cellulose acetate fiber modification
|
|
US8648069B2
(en)
|
2007-06-08 |
2014-02-11 |
Abbvie Inc. |
5-substituted indazoles as kinase inhibitors
|
|
US9213999B2
(en)
|
2007-06-15 |
2015-12-15 |
Kyoto University |
Providing iPSCs to a customer
|
|
JP2008307007A
(ja)
*
|
2007-06-15 |
2008-12-25 |
Bayer Schering Pharma Ag |
出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞
|
|
DK2173863T3
(en)
|
2007-06-29 |
2019-01-21 |
Fujifilm Cellular Dynamics Inc |
Automated method and apparatus for embryonic stem cell culture
|
|
WO2009032456A2
(en)
|
2007-08-01 |
2009-03-12 |
Primegen Biotech Llc |
Non-viral delivery of transcription factors that reprogram human somatic cells into a stem cell-like state
|
|
EP3078738B1
(en)
|
2007-08-31 |
2020-05-20 |
Whitehead Institute for Biomedical Research |
Wnt pathway stimulation in reprogramming somatic cells
|
|
CN101617043B
(zh)
|
2007-10-31 |
2014-03-12 |
国立大学法人京都大学 |
核重编程方法
|
|
US20110151447A1
(en)
|
2007-11-06 |
2011-06-23 |
Children's Medical Center Corporation |
Method to produce induced pluripotent stem (ips) cells from non-embryonic human cells
|
|
JP4604076B2
(ja)
|
2007-11-07 |
2010-12-22 |
国立大学法人静岡大学 |
燃料電池用電解質膜
|
|
EP2227540A4
(en)
|
2007-11-29 |
2011-11-02 |
Children S Hospital Of Orange County |
DIFFERENTIATION OF HUMAN CELLS
|
|
AU2008329563A1
(en)
|
2007-11-30 |
2009-06-04 |
Cytomatrix Pty Ltd |
Methods of inducing pluripotency involving Oct4 protein
|
|
US20110190729A1
(en)
|
2007-11-30 |
2011-08-04 |
Cytomatrix Pty Ltd |
Methods of inducing pluripotency involving sox2 protein
|
|
CN102027105B
(zh)
|
2008-03-17 |
2015-03-11 |
斯克里普斯研究所 |
用于产生诱导的多能干细胞的组合化学遗传方法
|
|
EP2268796A1
(en)
|
2008-03-17 |
2011-01-05 |
Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) |
Vectors and methods for generating vector-free induced pluripotent stem (ips) cells using site-specific recombination
|
|
CN101550406B
(zh)
|
2008-04-03 |
2016-02-10 |
北京大学 |
制备多潜能干细胞的方法,试剂盒及用途
|
|
KR20110006672A
(ko)
*
|
2008-04-07 |
2011-01-20 |
뉴포텐셜, 인크. |
Ｈｄａｃ 조절제의 사용을 통한 다능 유전자의 유도에 의한 세포 재프로그래밍
|
|
EP2128245A1
(en)
*
|
2008-05-27 |
2009-12-02 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Generation of induced pluripotent stem (iPS) cells
|
|
CN107012123A
(zh)
|
2008-07-30 |
2017-08-04 |
国立大学法人京都大学 |
有效建立诱导的多能干细胞的方法
|
|
WO2010019569A1
(en)
|
2008-08-12 |
2010-02-18 |
Cellular Dynamics International. Inc. |
Methods for the production of ips cells
|
|
US8298825B1
(en)
|
2008-08-25 |
2012-10-30 |
The General Hospital Corporation |
TGF-beta receptor inhibitors to enhance direct reprogramming
|
|
WO2010053472A1
(en)
|
2008-11-04 |
2010-05-14 |
Novocell, Inc. |
Stem cell aggregate suspension compositions and methods for differentiation thereof
|
|
CN105001196B
(zh)
|
2008-12-03 |
2017-05-10 |
斯克里普斯研究所 |
干细胞培养
|
|
ES2645869T3
(es)
|
2008-12-17 |
2017-12-11 |
The Scripps Research Institute |
Generación y mantenimiento de células madre
|
|
CA2688804A1
(en)
|
2008-12-17 |
2010-06-17 |
The Uab Research Foundation |
Polycistronic vector for human induced pluripotent stem cell production
|
|
WO2010102267A2
(en)
|
2009-03-06 |
2010-09-10 |
Ipierian, Inc. |
Tgf-beta pathway inhibitors for enhancement of cellular reprogramming of human cells
|
|
KR20110134939A
(ko)
|
2009-04-03 |
2011-12-15 |
더 맥클린 하스피털 코퍼레이션 |
유도된 다능성 줄기 세포
|
|
CN102395672A
(zh)
|
2009-04-13 |
2012-03-28 |
加利福尼亚大学董事会 |
用于干细胞培养的方法和组合物
|
|
CN102812122A
(zh)
|
2009-05-27 |
2012-12-05 |
索尔克生物学研究院 |
基因矫正的无疾病的诱导的多能干细胞的产生
|
|
US8524498B2
(en)
|
2009-05-29 |
2013-09-03 |
The General Hospital Corporation |
Methods and compositions for homologous recombination in human cells
|
|
EP2438159B1
(en)
|
2009-05-29 |
2018-10-03 |
Kyoto University |
Method for selecting clone of induced pluripotent stem cells
|
|
CN102625837B
(zh)
|
2009-08-07 |
2015-01-14 |
国立大学法人京都大学 |
有效建立诱导的多能干细胞的方法
|
|
EP4206319A1
(en)
|
2009-10-16 |
2023-07-05 |
The Scripps Research Institute |
Induction of pluripotent cells
|
|
BR112012009921B1
(pt)
|
2009-10-31 |
2021-06-29 |
New World Laboratories Inc |
Metodo para obter uma célula tronco neural
|
|
US9295697B2
(en)
|
2009-11-04 |
2016-03-29 |
Cellular Dynamics International, Inc. |
Episomal reprogramming with chemicals
|
|
US9018010B2
(en)
|
2009-11-12 |
2015-04-28 |
Technion Research & Development Foundation Limited |
Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
|
|
KR20120102709A
(ko)
*
|
2009-11-17 |
2012-09-18 |
어드밴스드 셀 테크놀로지, 인코포레이티드 |
인간 ｒｐｅ 세포의 생산 방법 및 인간 ｒｐｅ 세포의 제약 제제
|
|
WO2011090221A1
(en)
|
2010-01-22 |
2011-07-28 |
Kyoto University |
Method for improving induced pluripotent stem cell generation efficiency
|
|
US20130011918A1
(en)
*
|
2010-02-17 |
2013-01-10 |
Biotime Inc. |
Methods for telomere length and genomic dna quality control and analysis in pluripotent stem cells
|
|
US8486701B2
(en)
|
2010-03-05 |
2013-07-16 |
University Of Houston |
ETS2 and MESP1 generate cardiac progenitors from fibroblasts
|
|
ES2624780T3
(es)
|
2010-03-31 |
2017-07-17 |
The Scripps Research Institute |
Reprogramación de células
|
|
CN103003416B
(zh)
|
2010-06-15 |
2016-11-16 |
细胞动力学国际有限公司 |
从小体积的外周血产生诱导性多潜能干细胞
|
|
US20110306516A1
(en)
|
2010-06-15 |
2011-12-15 |
The New York Stem Cell Foundation |
Methods for producing induced pluripotent stem cells
|
|
JPWO2011158852A1
(ja)
|
2010-06-15 |
2013-08-19 |
国立大学法人 東京大学 |
誘導型多能性幹細胞の製造方法
|
|
US8765470B2
(en)
|
2010-08-04 |
2014-07-01 |
Cellular Dynamics International, Inc. |
Reprogramming immortalized B-cells to induced pluripotent stem cells
|
|
KR20140063501A
(ko)
|
2010-12-22 |
2014-05-27 |
페이트 세러퓨틱스, 인코포레이티드 |
단세포 분류 및 iPSC의 증강된 재프로그래밍을 위한 세포 배양 플랫폼
|
|
US9458131B2
(en)
|
2011-11-08 |
2016-10-04 |
Emory University |
Compounds and compositions used to epigenetically transform cells and methods related thereto
|
|
CA2858069C
(en)
|
2011-12-08 |
2020-02-11 |
Fred Hutchinson Cancer Research Center |
Compositions and methods for enhanced generation of hematopoietic stem/progenitor cells
|
|
WO2013159103A1
(en)
|
2012-04-20 |
2013-10-24 |
Whitehead Institute For Biomedical Research |
Programming and reprogramming of cells
|
|
EP2853590B1
(en)
|
2012-05-22 |
2018-11-07 |
The University of Tokyo |
Method for producing antigen-specific t cells
|
|
US9166832B1
(en)
|
2013-10-04 |
2015-10-20 |
Altera Corporation |
Methods and apparatus for decision feedback equalization adaptation
|
|
ES2966757T3
(es)
*
|
2014-03-04 |
2024-04-24 |
Fate Therapeutics Inc |
Métodos de reprogramación mejorados y plataformas de cultivo celular
|
|
WO2017066634A1
(en)
|
2015-10-16 |
2017-04-20 |
Fate Therapeutics, Inc. |
Platform for the induction & maintenance of ground state pluripotency
|
|
EP4249074A3
(en)
*
|
2015-11-04 |
2024-01-10 |
Fate Therapeutics, Inc. |
Genomic engineering of pluripotent cells
|